Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 100.95 | N/A |
| PEG Ratio (TTM) | 11.22 | N/A |
| P/S Ratio (TTM) | 17.02 | N/A |
| P/B Ratio (TTM) | 13.80 | N/A |
| P/FCF Ratio (TTM) | 97.66 | N/A |
| Price to 5YR AVG Earnings Ratio | -4,009.64 | N/A |
| Price to 5YR AVG FCF Ratio | 447.05 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.22% | N/A |
| ROE (TTM) | 14.85% | N/A |
| Net Profit Margin (TTM) | 16.84% | N/A |
| ROIC 5YR AVG | -1.02% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 102.74% | 334.36% | 177.82% |
| Revenue | 6.87% | 63.37% | 47.52% |
| Net Income | 99.20% | 358.26% | 191.97% |
| Cash Flow | 20.38% | 392.61% | 368.53% |
Health (88%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.10 | N/A |
| Quick Ratio (TTM) | 7.10 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 39.58 | N/A |
| LTL to 5YR AVG FCF | 3.62 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.96% | N/A |